Advertisement

Topics

35 States Sue Opioid-Maker Over Its Alleged Tactics For Keeping Generic Version Off Market

09:17 EDT 23 Sep 2016 | Kaiser Health News

The lawsuit claims that Indivior persuaded the FDA to approve a dissolvable strip version of their drug by raising concerns that the tablet posed high exposure risks to children. Even though the agency rejected the claims, by the time the generics hit the marketplace, many patients had already switched over.

Original Article: 35 States Sue Opioid-Maker Over Its Alleged Tactics For Keeping Generic Version Off Market

NEXT ARTICLE

More From BioPortfolio on "35 States Sue Opioid-Maker Over Its Alleged Tactics For Keeping Generic Version Off Market"

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...